MicroRNA interrelated epithelial mesenchymal transition (EMT) in glioblastoma

dc.contributor.authorSetlai, Botle Precious
dc.contributor.authorHull, Rodney
dc.contributor.authorReis, Rui Manuel
dc.contributor.authorAgbor, Cyril
dc.contributor.authorAmbele, Melvin Anyasi
dc.contributor.authorMulaudzi, Thanyani Victor
dc.contributor.authorDlamini, Zodwa
dc.contributor.emailprecious.setlai@up.ac.zaen_US
dc.date.accessioned2023-07-19T10:43:20Z
dc.date.available2023-07-19T10:43:20Z
dc.date.issued2022-01-27
dc.description.abstractMicroRNAs (miRNA) are small non-coding RNAs that are 20–23 nucleotides in length, functioning as regulators of oncogenes or tumor suppressor genes. They are molecular modulators that regulate gene expression by suppressing gene translation through gene silencing/degradation, or by promoting translation of messenger RNA (mRNA) into proteins. Circulating miRNAs have attracted attention as possible prognostic markers of cancer, which could aid in the early detection of the disease. Epithelial to mesenchymal transition (EMT) has been implicated in tumorigenic processes, primarily by promoting tumor invasiveness and metastatic activity; this is a process that could be manipulated to halt or prevent brain metastasis. Studies show that miRNAs influence the function of EMT in glioblastomas. Thus, miRNA-related EMT can be exploited as a potential therapeutic target in glioblastomas. This review points out the interrelation between miRNA and EMT signatures, and how they can be used as reliable molecular signatures for diagnostic purposes or targeted therapy in glioblastomas.en_US
dc.description.departmentImmunologyen_US
dc.description.departmentMedical Oncologyen_US
dc.description.departmentOral Pathology and Oral Biologyen_US
dc.description.departmentSurgeryen_US
dc.description.librarianam2023en_US
dc.description.sponsorshipSouth African Medical Research Council (SAMRC) and National Research Foundation (NRF).en_US
dc.description.urihttps://www.mdpi.com/journal/genesen_US
dc.identifier.citationSetlai, B.P.; Hull, R.; Reis, R.M.; Agbor, C.; Ambele, M.A.; Mulaudzi, T.V.; Dlamini, Z. MicroRNA Interrelated Epithelial Mesenchymal Transition (EMT) in Glioblastoma. Genes 2022, 13, 244. https://DOI.org/10.3390/genes13020244.en_US
dc.identifier.issn2073-4425 (online)
dc.identifier.other10.3390/ genes13020244
dc.identifier.urihttp://hdl.handle.net/2263/91543
dc.language.isoenen_US
dc.publisherMDPIen_US
dc.rights© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.en_US
dc.subjectAngiogenesisen_US
dc.subjectDrug resistanceen_US
dc.subjectMicroRNAs (miRNAs)en_US
dc.subjectEpithelial to mesenchymal transition (EMT)en_US
dc.titleMicroRNA interrelated epithelial mesenchymal transition (EMT) in glioblastomaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Setlai_MicroRNA_2022.pdf
Size:
2.77 MB
Format:
Adobe Portable Document Format
Description:
Article

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: